Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 30;26(1):146.
doi: 10.1186/s13075-024-03372-z.

IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro

Affiliations

IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro

L Andrés Cerezo et al. Arthritis Res Ther. .

Abstract

Introduction: IL-40 is a novel cytokine associated with autoimmune connective tissue disorders such as rheumatoid arthritis (RA) or Sjögren syndrome. We have previously shown an accumulation of IL-40 in the RA joint and its expression by immune cells and fibroblasts. Therefore, we aimed to assess the role of IL-40 in association with hyaline cartilage and chondrocyte activity.

Methods: Immunohistochemistry was employed to detect IL-40 in paired samples of loaded and unloaded regions of osteoarthritis (OA) cartilage (n=5). Synovial fluid IL-40 was analysed by ELISA in OA (n=31) and control individuals after knee injury (n=34). The impact of IL-40 on chondrocytes was tested in vitro.

Results: IL-40 was found in chondrocytes of the superficial zone of the OA cartilage, both in loaded and unloaded explants. Additionally, only biopsies from loaded explants showed significant IL-40 positivity in transitional zone chondrocytes. Levels of IL-40 were significantly elevated in the synovial fluid from OA patients compared to controls (p<0.0009) and correlated with synovial fluid leukocyte counts in OA (r=0.444, p=0.014). Chondrocytes exposed to IL-40 dose dependently increased in the secretion of pro-inflammatory cytokines IL-6 (p<0.0001) and IL-8 (p=0.004). Moreover, a dose dependent up-regulation of matrix degrading metalloproteinases MMP-1 (p=0.004), MMP-3 (p=0.031) and MMP-13 (p=0.0002) upon IL-40 treatment was observed in contrast to untreated chondrocytes.

Conclusion: This study is the first to demonstrate the accumulation of IL-40 in OA cartilage and its up-regulation in the synovial fluid of OA patients compared to controls. In addition, extracellular IL-40 appears to play a role in promoting inflammation and cartilage destruction by driving chondrocyte behaviour towards a more aggressive phenotype.

Keywords: Cartilage; Chondrocytes; Interleukin 40; Osteoarthritis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
IL-40 was highly expressed in the superficial and transitional zone chondrocytes in the loaded areas of OA cartilage. In the radial zone of loaded explants, IL-40 positive chondrocytes were found only in some patients (A, C). A. In the unloaded areas, superficial zone chondrocytes tested positive for IL-40, whereas only random IL-40 staining was found in transitional and radial zones (B, D). Semi‐quantitative analysis was performed to evaluate the percentage of the IL-40 positive cells in all analysed samples of loaded (C) and unloaded (D) cartilage explants (n=5). Rabbit IgG was used as isotype control (A, B). Safranin O – Fast Green and haematoxylin were used to assess the cartilage morphology (A, B). Representative images are shown at x40 and x200 magnification. Levels of IL-40 in the synovial fluid were significantly up-regulated in osteoarthritis (OA) patients compared to controls (E). No relation between synovial fluid IL-40 levels and radiographic severity (KL grade) was observed in OA patients (F). Synovial fluid IL-40 levels were positively associated with synovial fluid leukocyte counts in OA patients (G) The data are represented as the median; the error bars show 1st and 3rd quartiles. ***, p<0.001
Fig. 2
Fig. 2
Normal human articular chondrocytes (n=7-9) significantly increased the secretion of cytokines IL-6, IL-8 a matrix degrading metalloproteinases (MMPs) but not IL-1β upon the exposure to recombinant IL-40 (5-200 ng/ml) for 24h in in vitro conditions (A-F). The data are represented as the median; the error bars show 1st and 3rd quartiles. *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001

References

    1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis Lancet. 2019;393:1745–59. - PubMed
    1. Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66:101249. 10.1016/j.arr.2020.101249 - DOI - PubMed
    1. Chen T, Weng W, Liu Y, Aspera-Werz RH, Nüssler AK, Xu J. Update on Novel Non-Operative Treatment for Osteoarthritis: Current Status and Future Trends. Front Pharmacol. 2021;12:755230. 10.3389/fphar.2021.755230 - DOI - PMC - PubMed
    1. Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, et al. Identification of IL-40, a novel B cell-associated cytokine. J Immunol. 2017;199:3326–35. 10.4049/jimmunol.1700534 - DOI - PMC - PubMed
    1. Navrátilová A, Bečvář V, Hulejová H, Tomčík M, Štolová L, Mann H, et al. New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis. RMD Open. 2023;9:e002894. 10.1136/rmdopen-2022-002894 - DOI - PMC - PubMed

LinkOut - more resources